Low-dose aspirin use was linked to a 55% lower risk of colorectal cancer recurrence in people with a genetic mutation that ...

Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

A new study finds that the common over-the-counter medication Aspirin could significantly cut the risk of colorectal cancer ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

Colorectal cancer is the second most common cause of cancer-related death in women and the third most common in men. Since the 1980s, the incidence of colorectal cancer in individuals aged 50 and ...

Patients with inflammatory bowel disease had a higher risk for venous thromboembolism after surgery for colorectal cancer ...

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic ...

A woman was diagnosed with stage-3 colon cancer at age 24 and said she almost missed a major warning sign of the disease.

"If I would have known that so many young people were getting diagnosed with colon cancer, I would have taken the symptom ...

A new study led by researchers at the American Cancer Society (ACS) shows that the overall five-year cancer survival rates ...